Related Experiment Video
Updated: May 7, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Glutathione as a Potential Neuroprotectant Against MDMA-Induced Oxidative Stress, Neuroinflammation, and Apoptosis in
Oyedayo Phillips Akano1, Goodness Olatinwo2, Moses Agbomhere Hamed3
1Department of Physiology, Faculty of Basic Medical Sciences, Olabisi Onabanjo University, Ago Iwoye, Ogun State, Nigeria.
Abstract:
3,4-Methylenedioxymethamphetamine (MDMA), widely misused for its euphoric and stimulant properties, induces overt neurotoxicity in rodents and non-human primates and is associated with profound neurochemical and structural brain alterations. Its deleterious effects are primarily mediated through oxidative stress, neuroinflammatory responses, and apoptotic pathways. Glutathione, a crucial endogenous antioxidant, has been proposed as a potential neuroprotective agent capable of mitigating MDMA-induced cerebral damage.Sixty adult male Wistar rats were randomly assigned to six experimental groups and administered oral treatments for 56 days: MDMA (5 mg/kg or 15 mg/kg), glutathione (15 mg/kg), or their combinations. After treatment, brain tissues were harvested and evaluated for oxidative stress biomarkers (8-OHdG, MDA, GPx, GSH, GST, SOD), pro-inflammatory cytokines (MPO, NF-κB, TNF-α), ion transport enzymes (Na⁺/K⁺ ATPase, Ca²⁺ ATPase), neurotransmitter levels (dopamine, serotonin, AChE), and the apoptotic marker caspase-3. Histological analysis of the hippocampus was conducted to assess structural integrity. MDMA administration led to significant elevations in MDA and 8-OHdG, reductions in antioxidant enzymes (GPx, GST, GSH, SOD), upregulation of inflammatory mediators (MPO, NF-κB, TNF-α), and disruption of ion homeostasis via altered Na⁺/K⁺ ATPase and Ca²⁺ ATPase activities. Neurotransmitter imbalances were observed, characterized by increased AChE and serotonin levels and decreased dopamine. Caspase-3 activity was markedly elevated, indicating enhanced apoptosis. Co-administration of glutathione at low MDMA doses ameliorated these effects, restoring antioxidant defenses, suppressing inflammation, and preserving hippocampal architecture. However, its protective efficacy was notably diminished at higher MDMA concentrations. Glutathione confers partial neuroprotection against MDMA-induced neurotoxicity, particularly under moderate exposure conditions. Its antioxidative capacity contributes to the restoration of redox equilibrium and cellular integrity. Nonetheless, under high-dose MDMA exposure, the therapeutic potential of glutathione is limited, suggesting the necessity for complementary interventions targeting excitotoxicity and mitochondrial dysfunction.
Insights
Glutathione offers partial neuroprotection against MDMA-induced neurotoxicity in rats, particularly at lower doses by reducing oxidative stress and inflammation. Its effectiveness is limited at higher MDMA concentrations, indicating a need for combined therapies.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- 3,4-Methylenedioxymethamphetamine (MDMA) causes neurotoxicity via oxidative stress, inflammation, and apoptosis.
- Glutathione, an endogenous antioxidant, is investigated for its neuroprotective potential against MDMA damage.
Purpose of the Study:
- To evaluate the neuroprotective effects of glutathione against MDMA-induced neurotoxicity in a rat model.
- To assess the impact of combined MDMA and glutathione administration on oxidative stress, inflammation, neurotransmitter levels, and apoptosis in the brain.
Main Methods:
- Adult male Wistar rats were administered MDMA (5 or 15 mg/kg) and/or glutathione (15 mg/kg) orally for 56 days.
- Brain tissues were analyzed for oxidative stress markers, inflammatory cytokines, ion transport enzymes, neurotransmitters, and apoptosis.
- Histological examination of the hippocampus was performed.
Main Results:
- MDMA increased oxidative stress (MDA, 8-OHdG), inflammation (MPO, NF-κB, TNF-α), and apoptosis (caspase-3), while decreasing antioxidant enzymes and disrupting ion homeostasis.
- Neurotransmitter imbalances (altered dopamine, serotonin, AChE) were observed with MDMA exposure.
- Glutathione partially reversed MDMA-induced damage at lower doses but showed limited efficacy at higher MDMA concentrations.
Conclusions:
- Glutathione provides partial neuroprotection against MDMA toxicity by restoring redox balance and reducing inflammation, especially at moderate MDMA exposure levels.
- The therapeutic potential of glutathione is limited under high-dose MDMA exposure, suggesting the need for complementary therapeutic strategies.

